Literature DB >> 350035

The nature of myospherulosis of the upper respiratory tract.

J Rosai.   

Abstract

A case of myospherulosis of paranasal sinuses similar in appearance to those recently seen in St. Louis, Missouri, was examined to ascertain the nature of the sac-like structures seen in this disease. The morphologic features of these formations and their positivity with stains for hemoglobin, peroxidase, and lipofuscin strongly suggest that they represent collections of erythrocytes altered by a foreign substance. This interpretation was confirmed by experimental production of these structures by the action of tetracycline ointment on a pure preparation of human erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350035     DOI: 10.1093/ajcp/69.5.475

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  Myospherulosis in the operated temporal bone.

Authors:  J J Manni; H E Schaafsma; P P Vennix
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

2.  Ocular spherulocystosis.

Authors:  U Kini; M K Babu
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

Review 3.  Myospherulosis of the Mandible Presenting as a Multilocular Lesion: A Case Report and Review of the Literature.

Authors:  Priscilla LeBlanc; Julien E Ghannoum
Journal:  Head Neck Pathol       Date:  2015-07-10

Review 4.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

5.  Myospherulosis in the subcutis of a pony.

Authors:  A D Liggett; R Weiss; J L Blue
Journal:  Can J Vet Res       Date:  1987-01       Impact factor: 1.310

6.  Hepatic myospherulosis complicating portal vein embolisation.

Authors:  P C W Lui; I S C Luk; C K L Lee; Y H Lui; C Y Leung; C H Choi
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.